These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38957397)

  • 1. Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics.
    Elsori D; Pandey P; Ramniwas S; Kumar R; Lakhanpal S; Rab SO; Siddiqui S; Singh A; Saeed M; Khan F
    Front Pharmacol; 2024; 15():1406619. PubMed ID: 38957397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin: A potential flavonoid phytochemical for cancer therapy.
    Motallebi M; Bhia M; Rajani HF; Bhia I; Tabarraei H; Mohammadkhani N; Pereira-Silva M; Kasaii MS; Nouri-Majd S; Mueller AL; Veiga FJB; Paiva-Santos AC; Shakibaei M
    Life Sci; 2022 Sep; 305():120752. PubMed ID: 35779626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities.
    Stabrauskiene J; Kopustinskiene DM; Lazauskas R; Bernatoniene J
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management.
    Pandey P; Khan F; Alshammari N; Saeed A; Aqil F; Saeed M
    Front Pharmacol; 2023; 14():1154034. PubMed ID: 37021043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Effects of Naringenin on LPS-Induced Skin Inflammation by NF-κB Regulation in Human Dermal Fibroblasts.
    Choy YJ; Kim GR; Baik HU
    Curr Issues Mol Biol; 2024 Aug; 46(9):9245-9254. PubMed ID: 39329898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Naringenin: A Promising Immunomodulator for Anti-Inflammatory, Neuroprotective, and Anti-Cancer Applications".
    Solanki S; Vig H; Khatri N; Singh BP; Khan DMS; Devgun M; Wal P; Wal A
    Antiinflamm Antiallergy Agents Med Chem; 2024 Jul; ():. PubMed ID: 39076091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro.
    Wadhwa R; Paudel KR; Chin LH; Hon CM; Madheswaran T; Gupta G; Panneerselvam J; Lakshmi T; Singh SK; Gulati M; Dureja H; Hsu A; Mehta M; Anand K; Devkota HP; Chellian J; Chellappan DK; Hansbro PM; Dua K
    J Food Biochem; 2021 Jan; 45(1):e13572. PubMed ID: 33249629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activities of naringenin: A narrative review based on in vitro and in vivo studies.
    Uçar K; Göktaş Z
    Nutr Res; 2023 Nov; 119():43-55. PubMed ID: 37738874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
    Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
    Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer.
    Madureira MB; Concato VM; Cruz EMS; Bitencourt de Morais JM; Inoue FSR; Concimo Santos N; Gonçalves MD; Cremer de Souza M; Basso Scandolara T; Fontana Mezoni M; Galvani M; Rodrigues Ferreira Seiva F; Panis C; Miranda-Sapla MM; Pavanelli WR
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways.
    Zhao Z; Jin G; Ge Y; Guo Z
    Inflammopharmacology; 2019 Oct; 27(5):1021-1036. PubMed ID: 30941613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Review Summarizing the Anticancer Potential of Naringenin.
    Sharma S; Mishra A; Ramniwas S; Pandey P
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 39005120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin: its chemistry and roles in neuroprotection.
    Atoki AV; Aja PM; Shinkafi TS; Ondari EN; Awuchi CG
    Nutr Neurosci; 2024 Jun; 27(6):637-666. PubMed ID: 37585716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.
    Arafah A; Rehman MU; Mir TM; Wali AF; Ali R; Qamar W; Khan R; Ahmad A; Aga SS; Alqahtani S; Almatroudi NM
    Plants (Basel); 2020 Dec; 9(12):. PubMed ID: 33339267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro.
    Shi X; Luo X; Chen T; Guo W; Liang C; Tang S; Mo J
    J Cell Mol Med; 2021 Mar; 25(5):2563-2571. PubMed ID: 33523599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel regulatory mechanism of naringenin through inhibition of T lymphocyte function in contact hypersensitivity suppression.
    Fang F; Tang Y; Gao Z; Xu Q
    Biochem Biophys Res Commun; 2010 Jun; 397(2):163-9. PubMed ID: 20471963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
    Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
    Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin is an inhibitor of T cell effector functions.
    Niu X; Wu C; Li M; Zhao Q; Meydani SN; Wang J; Wu D
    J Nutr Biochem; 2018 Aug; 58():71-79. PubMed ID: 29885599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.